Health and Wellness
Also: Decentralized clinical trial startup Curebase names vice president of clinical operations, and digital opioid use disorder-treatment company Ophelia hires a chief technology officer.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
The newly public company, now trading on Nasdaq under the ticker symbol "AKLI," will use the proceeds from the transaction to launch EndeavorRx, its video game-like digital therapeutic for children with ADHD.
One of the projects will develop a digital navigator to support people with chronic conditions.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.
The startup connects new mental health providers with supervisors to complete their licensure requirements. The new funding brings its total raise to $16.3 million.
Medication management-focused Arine raised $29 million, Epic-based virtual care platform KeyCare scooped up $24 million, and care coordination software company CareHarmony raised $15 million.
After an emergency call, patients who overdose or have symptoms of opioid use disorder can be referred to Bicycle Health for treatment.